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ABSTRACT
Objective: With a rise in multidrug resistant (MDR) bacterial isolates, search for antibiotics or compounds that could act synergistically with themis a significant area of research. Efflux-mediated resistance, in particular, is a great hurdle that needs to be overcome. In an effort to identify suchsynergistic compounds and potential efflux pump inhibitors (EPI), we analyzed the rind of Punica granatum (pomegranate) against MDR clinical
Klebsiella pneumoniae isolates.
Methods: Sequential fractionation of P. granatum rind ethanol (PGR) extract was carried out to obtain hexane, butanol and water fractions.Antibacterial activity of the plant extracts was confirmed, and synergistic interaction with antibiotics was determined by the checkerboard assay. Gaschromatography-mass spectrometry (GC-MS) analysis was performed to identify the phytochemical constituents of the hexane extract. To study EPIactivity of the extracts, norfloxacin accumulation assay was carried out.
Results: PGR ethanol extract was found to have synergistic activity with ciprofloxacin, levofloxacin, ceftazidime, cefoxitin, meropenem, and gentamicinresulting in fold decrease of minimum inhibitory concentration (MIC) ranging from 2 to 32 fold. The hexane fraction was found to have maximumsynergistic activity resulting in a 32-fold reduction of ciprofloxacin MIC followed by butanol and water fractions. The PGR ethanol extract was alsofound to have efflux inhibition activity by the norfloxacin accumulation assay. Of the sequential fractions, the butanol fraction had maximum effluxinhibition activity.
Conclusion: Therefore, our study shows that PGR extract can potentiate the effect of antibiotics on MDR bacteria, and the mode of action is likely tobe due to EPI.
Keywords: Punica granatum rind, Pomegranate, Synergy with antibiotics, Multidrug resistant, Klebsiella pneumoniae, Efflux pump inhibition.© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i3.16000
INTRODUCTIONMultidrug resistance (MDR) is increasing worldwide at an alarmingrate [1]. To combat  this,  stronger  antibiotics in higher dosages areprescribed, thereby resulting in a vicious cycle of further resistance.
Klebsiella pneumoniae, an opportunistic pathogen, causes numerousdiseases like Pneumonia, bloodstream infections, wound or surgicalsite infections, urinary tract infections and meningitis; with nosocomialinfections, they possess a threat to patients with low immunity [2]. Theirmultidrug resistant nature poses serious healthcare issues. One of thereasons for high resistance is attributed to high efflux pump activity [3].Efflux pumps are transport proteins that extrude toxic substancesincluding antibiotics from the bacterial cells thereby resulting inresistance [4]. Efflux pump inhibitors (EPI) have a potential use inmaking antibiotics more effective against MDR strains [5]. However, thewell-known EPIs-carbonyl cyanide m-chlorophenylhydrazone (CCCP),PAβN, reserpine, berberine, and verapamil [6] are toxic in nature andcannot be used commercially. Therefore, we focused on identifying EPIfrom natural products.
Punica  granatum (pomegranate)  has  historically  been  known tohave medicinal properties and has been used in herbal medicine totreat cancer, diarrhea, diabetes, blood pressure, leprosy, dysentery,hemorrhages, bronchitis, dyspepsia, and inflammation. It is also knownto have antibacterial, antifungal, and anticancer activity [7]. While theantimicrobial activity of P. granatum pericarp (peel and rind) has beendemonstrated [8,9] and its mode of action still remains unknown.
In this study, we analyzed the synergistic activity of P. granatum rind(PGR) extract with various classes of antibiotics against clinical MDRisolates of K. pneumoniae using the checkerboard assay [10]. Further,we confirmed the activity by sequential fractionation of the extract. Thehexane extract which showed the best synergistic interaction was studiedby gas chromatography-mass spectrometry (GC-MS) and potentialcompounds were identified. The ethanol extract was also shown toincrease the intracellular norfloxacin accumulation, suggesting that itcould be an EPI. When the sequential fraction was tested, it was foundthat the butanol fraction had maximum efflux inhibition activity. Theidentification of such EPI from natural products can lead to antibioticcombinations which are more effective against MDR isolates.
METHODS
GeneralThe following chemicals were obtained from Sigma-Aldrich:Ciprofloxacin, norfloxacin, CCCP, magnesium sulfate, glycinehydrochloride, potassium l-lactate, and trizma hydrochloride. Resazurin,sodium hydroxide, Mueller-Hinton broth and agar, Luria Bertani brothand agar, Nutrient broth and agar and dimethyl sulfoxide were obtainedfrom Himedia Laboratories Pvt. Ltd., Mumbai, India. Solvents-Ethanol,n-hexane, and n-butanol were obtained from Qualigens.
Bacterial isolatesAbout  22  MDR  isolates were  collected  from tertiary  care  hospitalsin Chennai. MDR nature of these isolates was clarified by
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antibiotic   susceptibility testing using the antibiotics   norfloxacin(NX-10 µ g), nalidixic acid (NA-30 µ g), ciprofloxacin (CF-5 µ g), amoxyclav(AMC-30 µg), cefotaxime (CTX-30 µg) cefepime (CPM-30 µg), cefoxitin(Cn-30 µg), and imipenem (IMP-10 µg) from (Himedia Laboratories Pvt.Ltd., Mumbai, India). The results were interpreted as per the EUCASTguidelines. K. pneumoniae MTCC 432 was used as a control strain.
Plant material and extractionThe  rind  of P.  granatum variety  Bhagwa was  obtained  from  M/S“Sam Agritech, Hyderabad.” The product was  aseptically  separatedand  shade  dried.  The  dried  material  (1.5 kg) was  ground,  sievedand macerated with ethanol in the ratio 1:3 and kept for 5 days withintermittent shaking. The extract was filtered with Whatman number 1filter paper (125 mm) and collected. It was then placed in a rotaryvacuum evaporator and concentrated under pressure to give 100 gof a viscous material. 90 g of this crude extract was then dissolved inwater, and sequential extraction was carried out resulting in hexane,butanol and water fractions which were concentrated in rotary vacuumevaporator [11].
Antibacterial activityThe antibacterial activity was tested by determining the minimuminhibitory concentration (MIC) of the plant extract using a stock solutionof the plant extract (50 mg/ml of 50% dimethyl sulfoxide [DMSO]) bythe resazurin assay [12]. The experiment was done in triplicates andpositive control (isolate +LB broth), negative control (LB broth), andsolvent control (50%DMSO + isolate +LB broth) were maintained. Todetermine the MIC of ciprofloxacin, the same experimental procedurewas followed with stock solution of ciprofloxacin (100 mg/ml) addedto the first well instead of the plant extract.
Synergistic studiesSynergistic interaction with ciprofloxacin was determined bycheckerboard assay [13], in which 36 different combinations of plantextract and ciprofloxacin are tested to determine the best combination.The interaction between the antibiotics and plant extract wasdetermined and quantified by calculating the fractional inhibitoryconcentration index (FICI) using the following formula:
FIC index = MIC of plant extract in combinationMIC of plant extract alone+ MIC of antibiotic in combinationMIC of antibiotic alone
Interpretation of the FICI [13]: FICI = 0.5 synergy - joint effect is greaterthan sum of individual activity. FICI >0.5 to 4 indifference - joint effectis equal to sum of individual activity. FICI >4 antagonism - joint effect isless than sum of individual activity or effect of individual activity.
GC-MS analysisGC-MS analysis of the PGR hexane extract was carried out using anAGILENT (Hewlett Packard) GC 5890, MS 5973 system. The followingconditions were maintained for GC analysis. A HP-5 ms Agilent columnwas used (30 × 0.25 μm ID × 0.25 µmdf). Helium gas 99.9995% puritywas used as a carrier with an injection volume of 1 µl (split ratio 20)and a flow rate of 1 ml/minute. The injector temperature wasmaintained at 250°C, and the oven temperature was programed at 35°C(for 2 minutes), with an increase to rate 15, 280°C for 5 minutes, lastingfor a total of 35 minutes. Mass spectra were taken at 70 eV with a scanrange 40-700 m/z. the solvent cut time was 1 minute, scan speed was2000 and the total GC/MS running time was 36 minutes. Peaks wereidentified according to the MS library- NIST 11
Norfloxacin accumulation assayEfflux inhibition activity was determined by the norfloxacinaccumulation assay [14]. In this assay, the norfloxacin accumulationis determined by the fluorescence of supernatants measured as EX(excitation) at 281 nm and EM (emission) at 440 nm with a Shimadzu
RF-5301pc fluorescence spectrophotometer. The experiment wascarried out in triplicate.
RESULTS AND DISCUSSION
Synergistic interaction between PGR ethanol extract and
ciprofloxacinThe antimicrobial activity of PGR extract is known but the modeof action is unknown. To  identify  the mode of action, we analyzedthe synergistic activity of the ethanol extract with antibiotics. Asfluoroquinolone resistance  is  normally  associated  with  nosocomial
K. pneumoniae infections [15] and efflux-mediated resistance [16],ciprofloxacin-resistant strains were chosen for our study.Our first step was to determine the ciprofloxacin resistance of the22 clinical K. pneumoniae strains by determining MIC. As per the EUCASTguidelines, the ciprofloxacin breakpoint MIC is  1  µg/ml. 20  of  the
K. pneumoniae strains varied from high resistance (780 µg/ml) to lessresistance (12 µg/ml) while two of them were found to be ciprofloxacinsensitive (Table 1). The antibacterial activity of PGR ethanol extractwas determined by the MIC and was found to range from 25000 to6250 µg/ml. From this, we infer that on its own, a high amount of plantextract is required to inhibit bacteria. It was also noted that, even for thetwo strains which were ciprofloxacin sensitive, a high amount of PGRextract was required to inhibit the bacteria (Table 1). The control strain
K. pneumoniae MTCC 432 was ciprofloxacin sensitive, and the MIC ofPGR ethanol extract was 195 µg/ml.WethentestedforsynergybetweenPGR ethanolextract andciprofloxacinby the checkerboard assay [10,13]. 36 different combinations weretested and the optimum combination of ciprofloxacin and plant extractconcentration was determined. Based on an FICI, the combinationswere classified as synergistic, antagonistic, and indifferent.In 13 of the 20 strains, synergistic activity of PGR and ciprofloxacin wasobserved. In four of these strains, a 32-34 fold decrease in ciprofloxacinMIC was observed when in the presence of the PGR ethanol extract.Seven of the strains showed an 8-24 fold decrease and only 2 strainsshowed a 2-4 fold reduction of MIC. One of the strains K35 showed a24-fold reduction of ciprofloxacin MIC in the presence of PGR making ita sensitive strain (MIC=0.5 µg/ml after combining with ethanol extract).These data show that the addition of PGR ethanol extract can reduce theciprofloxacin MIC in K. pneumoniae isolates.Further, despite the fact that seven strains out of 20 were classified asindifferent; a fold reduction was found in the MIC of ciprofloxacin inthe presence of PGR. Of these, three strains showed an 8-fold reduction,three showed a 4-fold reduction and one showed no change.As the ethanol extract of PGR had very good synergistic activity withciprofloxacin (up to 34-fold reduction of MIC and re-sensitization ofa resistant strain), we decided to determine whether the synergismof PGR extract was specific to ciprofloxacin or if it could interact withother antibiotics as well.
Synergistic interaction with other classes of antibioticsOnce it was determined that the PGR ethanol extract workedsynergistically with ciprofloxacin and resulted in a reduction of theantibiotic MIC, we decided to study its interaction with other antibiotics.The synergistic interaction with other classes of antibiotics such ascephalosporins, β-lactams, and aminoglycosides was determined fora representative K. pneumoniae strain U25 which showed a 16-foldreduction in MIC of ciprofloxacin and is known to have high effluxactivity [17].Out of the 12 antibiotics tested, 6 of them - ciprofloxacin, levofloxacin,ceftazidime, cefoxitin, meropenem and gentamicin, exhibited synergismwith the ethanol extract for the strain U25 (Table 2). Ciprofloxacinshowed maximum synergism with the ethanol extract showing a
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16 fold reduction, followed by cefoxitin and meropenem showing a12 and 8 fold reduction, respectively. Levofloxacin, gentamicin, andceftazidime were found to decrease 4-fold in combination with ethanolextract.In the 6 antibiotics in which indifference was noted, a 2-4 fold reductionof antibiotic was noted except for oxacillin where a 32-fold reductionwas noted. In the case of oxacillin, despite the fold reduction being sohigh, it is classified as indifferent as the highest concentration of plantextract is used.This shows that while the PGR ethanol extract shows synergy over abroad spectrum of antibiotics, the highest reduction of MIC was notedin combination with ciprofloxacin.This supports the fact that the PGR ethanol extract could have potentialEPI activity.As our objective is to identify compounds with efflux inhibition activity,we sequentially fractionated the ethanol extract with low polar hexaneand highly polar butanol in a hope to extract single compounds.
Synergistic extraction with the sequential plant fractionsOnce the synergistic activity of the PGR ethanol extract with ciprofloxacinwas determined, sequential hexane, butanol and water fractions wereobtained and were found to have antibacterial activity (data notshown). The checkerboard assay was carried out to determine if thesequential fractions as well exhibited synergism with ciprofloxacin.Four representative strains were chosen for this assay, two in which,ethanol extract-antibiotic synergism activity was found (U25, K15) andtwo in which indifference was noted (K21, K37).It was found that all of the sequential fractions-hexane, butanol andwater, exhibited synergistic interaction with ciprofloxacin (Table 3).Even the strains K21 and K37 in which indifference was seen with theethanol extract, synergism was seen with the sequential fractions andciprofloxacin.The hexane fraction showed maximum synergistic activity withciprofloxacin. The strains U25 and K15 which showed a 16 fold MICreduction with ethanol extract, exhibited a 32-fold reduction withhexane fraction. An 8-32 fold reduction was seen with the water fractionwhile the butanol fraction showed a 2-4 fold reduction.
Table 1: Synergistic interaction between Punica granatum rind ethanol extract and ciprofloxacin
Strain MIC µg/ml FIC Interpretation
Ciprofloxacin PGR ethanol Ciprofloxacin/PGR ethanol concentrationK38 780 6250 390/390 0.56 SynergyK14 625 25000 39/12500 0.56 SynergyK13 625 25000 78/6250 0.37 SynergyU25 390 12500 24/6250 0.56 SynergyK21 390 25000 97.5/12500 0.75 IndifferenceK3 390 25000 24/12500 0.56 SynergyK39 390 6250 12/3125 0.53 SynergyK31 312.5 12500 9.75/6250 0.53 SynergyK32 312.5 12500 9.75/6250 0.53 SynergyK15 312.5 25000 19.5/12500 0.56 SynergyK12 312 12500 78/3125 0.50 SynergyK9 312 12500 39/12500 1.13 IndifferenceK36 156 6250 156/6250 2.00 IndifferenceK29 156 12500 4.5/6250 0.53 SynergyK11 78 25000 20/12500 0.76 IndifferenceK34 78 12500 9.75/6250 0.63 IndifferenceK40 45 6250 5.5/1560 0.37 SynergyK28 39 12500 4.5/12500 1.12 IndifferenceK37 12 6250 3.5/6250 1.29 IndifferenceK35 12 25000 0.5/12500 0.54 SynergyK10 S 25000 ND ND NDK33 S 12500 ND ND NDMTCC 432 S 195 ND ND NDMIC: Minimum inhibitory concentration, FIC: Fractional inhibitory concentration where FIC of<0.5 is considered and>0.5 to 4 as indifference, PGR: Punica granatumrind, ND: Not determined, P. granatum: Punica granatum
Table 2: Synergistic interaction between Punica granatum rind ethanol extract and other antibiotics for the strain U25
Antibiotic MIC µg/ml FIC Interpretation
AB MIC for U25 PGR ethanol Antibiotic/PGR ethanol concentrationCiprofloxacin 390 12500 24/6250 0.56 SynergyNalidixic acid 6250 12500 3125/6250 1.00 IndifferenceLevofloxacin 390 12500 97.5/1560 0.37 SynergyNorfloxacin 6250 12500 3125/3125 0.75 IndifferenceChloramphenicol 780 12500 195/6250 0.75 IndifferenceCeftazidime 25000 12500 6250/3125 0.50 SynergyCefotaxime 25000 12500 12500/3000 0.74 IndifferenceCefoxitin 625 12500 50/6250 0.58 SynergyMeropenem 62.5 12500 7.8/1560 0.25 SynergyOxacillin 50000 12500 1560/12500 1.03 IndifferenceCloxacillin 25000 12500 12500/3125 0.75 IndifferenceGentamicin 12500 12500 3125/1560 0.37 Synergy
P. granatum: Punica granatum, MIC: Minimum inhibitory concentration, AB: Antibiotic, FIC: Fractional inhibitory concentration where FIC of≤0.5 is considered and>0.5to 4 as indifference, PGR: Punica granatum rind
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Table 3: Synergistic interaction between ethanol extract, sequential fractions in hexane, butanol and water with ciprofloxacin
MIC in µg/ml
Culture CIP PGR CIP+PGR Activity CIP+PGR Activity CIP+PGR Activity CIP+PGR Activity
extract butanol hexane fraction water fraction ethanol extract
fractionU25 390 25000 97.5/1560 S 12/12500 S 48.5/780 S 24/6250 SK15              312.5 25000 156/780 S 10/12500 S 10/12500 S 19.5/12500 SK21              390 25000 97.5/6250 S 120/6250 S 156/3120 S 97.5/12500 IK37              12 25000 S S 6/1560 S 6/1560 S 3.5/6250 I
MIC: Minimum inhibitory concentration, CIP: Ciprofloxacin, PGR: Punica granatum rind, S: Synergy, I: Indifference, P. granatum: Punica granatum
,
The strains K21 and K37 in which indifference was seen with theethanol extract and showed synergy with all three solvent fractionresulting in a 2-4 fold reduction of ciprofloxacin MIC. The strain K37 waseven made sensitive with the butanol fraction - antibiotic combination.From this, we can infer that each of the fractions has synergistic activity,but the highest fold reduction of MIC is seen in the hexane fraction. Todetermine the active compounds that could play a role in the synergism,GC-MS of this fraction was carried out.
GC-MS analysisGC-MS  analysis  plays  a  major role  in  identifying  active  compoundsin   plant extracts   [18].   The   phytochemical   constituents   of thehexane fraction which exhibited very good synergistic activity withciprofloxacin were analyzed by GC-MS. Eight peaks of interest indicatingphytochemical constituents were observed (Fig. 1). On comparison ofthe spectra with the NIST database, the compounds were identified(Table 4). The results showed that the major components were linoleicacid ethyl ester and hexadecanoic acid ethyl ester with an area % of36.21 and 24.83, respectively. This is followed by ethyl 9-hexadecenoate(13.45%),   n-hexadecanoic   acid   (7.79%), octadecanoic   acid,   ethylester (6.02%), eicosanoic acid, ethyl ester (1.31%), octadecanoic acid(1.11%), and nonadecanoic acid ethyl ester 0.94%.These  are fatty  acids  and  their  esters whose  antimicrobial  activityhas been observed [19]. These fatty acids and their esters might beinteracting with the bacterial membrane to enhance the susceptibilityto  antibiotics. To  specifically  find  out  if  the  PGR extracts  had  aneffect of the efflux pumps, we tested the fractions by the norfloxacinaccumulation assay [14].
EPI activityThe efflux inhibition activity of PGR ethanol extract and the hexane,butanolandwaterfractionwasanalyzedbythe norfloxacinaccumulation
assay [14] using a representative K. pneumoniae isolate U25 which isknown to have high efflux activity [17]. A well-known EPI CCCP thatdissipates the proton gradient was used as a control [20]. In this assay,the amount of norfloxacin accumulated within the cell is estimated afterthe addition of an EPI. It was found that on addition of PGR ethanolextract a high intracellular accumulation of norfloxacin was seen. Whencompared to the standard CCCP, the PGR ethanol extract was found tolead to higher intracellular norfloxacin accumulation (Fig. 2).When the sequential fractions were tested, it was found that additionof the butanol fraction resulted in higher norfloxacin accumulation.Despite the fact that the hexane fraction showed maximum synergisticactivity, it was found that the butanol fraction had a much higher EPIactivity. These data suggest that the components of PGR butanol fractioncan inhibit the efflux pumps, and therefore, one or more componentscould be a potential EPI.Studies have been carried out with the PGR extract by disc diffusionmethod and MIC [9 21] against MTCC strains (using 1 K. pneumoniaeisolate) and methicillin resistant Staphylococcus aureus, respectively.Our report analyses the synergistic activity of PGR extract withantibiotics using the checkerboard method against 22 clinical isolatesof MDR K. pneumoniae.Studies have also found that P. granatum has the ability to inhibit NorAefflux pumps in Staphylococcus aureus [22]. Taken together with ourdata, it is likely that PGR butanol fraction inhibits the efflux pumps in K.
pneumoniae. Further analysis of the compounds in the butanol fractionis in progress.
P. granatum tannins punicalagin, punicalin, and ellagic acid have beenfound to specifically block the HCV NS3/4A protease activity in vitroand have been found to be bioavailable [23].
Fig. 1: Gas chromatography-mass spectrometry profile of Punica granatum rind Hexane fraction
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Table 4: Compounds from PGR hexane fraction identified by
GC-MS analysis
Retention time Name of compound Area %13.85 Ethyl 9-hexadecenoate 13.4513.982 Hexadecanoic acid, ethyl ester 24.8314.201 n-Hexadecanoic acid 7.7914.639 Octadecanoic acid 1.1115.17 Linoleic acid ethyl ester 36.2115.377 Octadecanoic acid, ethyl ester 6.0217.604 Eicosanoic acid, ethyl ester 1.3121.401 Nonadecanoic acid, ethyl ester 0.94PGR: Punica granatum rind, GC-MS: Gas chromatography-mass spectrometry
Fig. 2: Efflux inhibition activity of Punica granatum rind ethanol
extract and sequential fractions
Our study shows that PGR extracts have synergistic activity withciprofloxacin and the butanol soluble fraction from PGR specificallyinhibits efflux pump activity. Analyzing leads from traditionalknowledge to identify compounds that can be used as adjuvant forantimicrobial therapy is an important field of research. The use of suchsynergistic compounds can re-sensitize resistant isolates and makeantimicrobial therapy more efficient.
CONCLUSIONIn this report, we show that PGR ethanol extract exhibits a consistentreduction of antibiotic MIC. Even in the strains that the plant-antibioticinteraction was classified as indifferent, a fold reduction of the antibioticis still seen. This synergistic interaction was seen with a broad spectrumof antibiotics such as ciprofloxacin, levofloxacin, ceftazidime, cefoxitin,meropenem, and gentamicin. To identify the individual compoundswith EPI activity, sequential extraction of the PGR ethanol extract wasdone. Of the sequential fractions, the hexane fraction was found to havethe most synergistic activity with ciprofloxacin, resulting in a 32-foldreduction of MIC. The mode of action of PGR ethanol and sequentialfractions were also studied and it was found that addition of PGR extractresults in increased intracellular norfloxacin accumulation. In this case,it was found that the PGR butanol fraction had the best EPI activity. Thisindicates one or more components of the PGR butanol fraction could bea potential EPI.
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